在preserflo微缩植入后2年,手术成功:来自单个眼科中心的真实数据
Sarah Hinterberger1, Sophie Schneider2, Martin Kallab2
1Department of Ophthalmology and Optometry, Kepler University Hospital, Johannes Kepler University, Krankenhausstraße 9, 4020, Linz, Austria. sarah.hinterberger@kepleruniklinikum.at.
概括
在现实世界眼患者队列中,Preserflo MicroShunt (PM) 在两年内降低眼内压 (IOP) 的总成功率为60.53%. 这项研究证实了该程序后持续的内膜压力降低和减少药物使用.
科学领域:
- 眼科医生 眼科 眼科
- 玻璃眼的手术 玻璃眼的手术
- 医疗器械 医疗器械
背景情况:
- Preserflo MicroShunt (PM) 是一个公认的手术选择,用于降低眼内压力 (IOP).
- 现有研究表明,对初级开角青光眼的治疗效果和安全性与带切除术相似.
研究的目的:
- 评估Preserflo MicroShunt (PM) 在现实世界中的有效性和安全性.
- 在一个单一的三级眼科护理中心评估一组多样化的青光眼患者的结果.
主要方法:
- 从2019年到2022年对PM植入物的回顾性分析.
- 通过使用WGA标准的完整,合格和整体成功率来衡量结果.
- 二次结局包括眼内压 (IOP) 和药物使用.
主要成果:
- 这项研究包括38名患者.
- 24个月后,完全成功率为31.58%,合格成功率为28.95%,失败率为39.47%.
- 在成功的病例中,平均内血压下降了55.2% (从25.57 mmHg降至11.45 mmHg),药物使用从2.73降至1.14.
结论:
- 手术后两年,整体成功率为60.53%.
- 在为期两年的随访期间,IOP的显著降低一直保持不变.
- 现实世界的数据支持Preserflo MicroShunt在各种青光眼亚型中的持续有效性.
更多相关视频
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...


